Source link : https://www.newshealth.biz/health-news/another-promising-target-for-liquid-biopsy/
SAN DIEGO — A new blood test that combines cell-free DNA fragmentomes and protein biomarkers to screen for ovarian cancer shows promising results, according to an initial analysis. The test, under development by Delfi Diagnostics, “looks very sensitive for detecting ovarian cancer early,” said company founder and board member Victor Velculescu, MD, PhD, who is […]
Author : News Health
Publish date : 2024-04-12 11:18:56
Copyright for syndicated content belongs to the linked Source.